Informed Consent
All authors must declare that informed consent has been obtained (or the permission consent of their parent or guardian in the case of children under 16 and the child has provided assent), that participation is completely voluntary, and that all reasonable steps have been taken to maintain subject’s confidentiality, including artistic artifacts, music, illustrations, which should be de-identified and anonymized. It is the responsibility of the author, not the journal, to acquire all relevant consents, and formalities, permissions related to the human subjects research.
Clinical Trials Registration
The journal adheres to ICMJE’s
Clinical Trials Registration Statement. All clinical trials published in the journal must
be registered in a public trial’s registry at or before the onset of participant enrolment. Manuscripts should include
the exact URL and unique identification number for the trial registration at the time of submission. This information
will be published in the article, and we ask that you include the URL and identification number on the title page of
your manuscript.
For any clinical trials commencing prior to 2008, retrospective registration will be accepted. A list of recommended
registries can be found on the
ICMJE website. Results posted in the same clinical trials registry in which the primary
registration resides will not be considered prior publication if they are presented in the form of a brief abstract (500
words or less) or a table.
Clinical trials must be reported according to the relevant reporting guidelines, i.e.
CONSORT for randomized controlled
trials,
TREND for non-randomized trials, and
other specialized guidelines as appropriate. The intervention should be
described according to the requirements of the
TIDieR checklist and guide. Submissions must also include the study
protocol as supporting information, which will be published with the manuscript if accepted.
Authors of manuscripts describing the results of clinical trials must adhere to the
CONSORT reporting guidelines
appropriate to their trial design, available on the
CONSORT Statement web site. Any deviation from the trial protocol
must be explained in the paper. Authors must explicitly discuss informed consent in their paper, and we reserve the
right to ask for a copy of the patient consent form.
Research published in CAET include empirically based research (arts-based), mixed-methods, quantitative, qualitative,
theoretical (literature), and historical.
It is not required, but recommended that authors consider the following format for any empirical research:
Title: No more than 12 words.
Introduction Section: Introduce the topic, Identify the problem being investigated and the compelling rationale and
reasons for investigating it, and how this project might solve that problem. Include a review of the literature
pertinent to the topic.
Method Section: Provide the description of the design (interview, arts technique), details of the steps and procedures
being followed, as well as equipment, tools, instruments being used.
Results Section: Offer a clear presentation of the findings from the study of the empirical data. Present the results in
as clear and sensible way as possible for readers to be able to understand and infer their own perspectives.
Discussion Section: Provide a clear, organized discussion of the key findings from the study, and highlight any
surprises, or stand-out results that generate a broader dialogue. Provide a summary of the impact of the research,
including the limitations of the study, and how findings will be transferred into practice and/or teaching. Provide
recommendations based on the findings for future research.